Which of the Big Pharma companies will cure us from superbugs?
Superbugs and antibiotic resistance have been troubling the United States, Europe, and Italy for years. Resources and political measures have been implemented, yet according to experts, the pipeline for new drugs is “alarmingly scarce.” Here are which pharmaceutical companies are doing better (and which worse). Facts, names, and comments.
